Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review
NeuroMarkers · 2025
DOI: 10.1016/j.neumar.2025.100037 ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMarkers, 2025. Verfasst von Dhruv Parikh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Parkinson's disease is a major global nervous system disorder with few treatment options, primarily focused on symptom management. This review summarizes research on epigenetic therapy in Parkinson's disease , with a particular emphasis on epigenetic markers as biomarkers and therapeutic targets. It aims to assess the therapeutic potential of epigenetic phenomena, including DNA methylation , histone modifications , and non-coding RNAs, and to discuss how these molecular mechanisms can be integrated into disease-modifying strategies. Our objective is to provide a comprehensive overview of the roles of these epigenetic factors in Parkinson's disease pathogenesis and their therapeutic applications. We investigate the role of DNA methylation in regulating key genes such as SNCA , explore the potential of histone modifications as neuroprotective agents through HDAC inhibition, and examine how non-coding RNAs, particularly microRNAs , can modulate Parkinson's disease-related pathways. We also compare various strategies, emphasizing their unique benefits and challenges. This review summarizes current studies on epigenetic therapies for Parkinson's disease, emphasizing significant gaps in therapeutic specificity and delivery. Ultimately, we present a roadmap for future research aimed at overcoming these obstacles to promote the development of more effective, disease-modifying treatments for Parkinson’s disease.
Zitieren
APA
Parikh, D., & Shah, M. (2025). Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review. NeuroMarkers. https://doi.org/10.1016/j.neumar.2025.100037
Vancouver
Parikh D, Shah M. Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review. NeuroMarkers. 2025. doi:10.1016/j.neumar.2025.100037
BibTeX
@article{Parikh2025,
author = {Parikh, Dhruv and Shah, Manan},
title = {Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review},
journal = {NeuroMarkers},
year = {2025},
doi = {10.1016/j.neumar.2025.100037}
}
EUVIMED